Niraparib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer
Clinical trial NCT04507841 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04507841
- Sponsor
- Tongji Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-08
- Primary completion
- 2023-09-25
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.